SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

DSM-Firmenich Reports Q3 Adjusted EBITDA Margin of 20.4%

The margin compares with DSM-provided consensus of 20.3%.

SquawkNews Desk

Related stories

Lal PathLabs Reports September-Quarter Consolidated Revenue of 8.74 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 07:59 AM UTC Lal PathLabs Reports September-Quarter Consolidated Net Profit of 1.92 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 07:59 AM UTC Marksans Pharma September-Quarter Revenue From Operations at 9.40 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 07:58 AM UTC Marksans Pharma Reports September-Quarter Consolidated Net Profit of 1.41 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 07:58 AM UTC Pandora Raises 2026 Targets on Demand for New Products Pandora raised its 2026 targets, supported by demand for new products. M impact | EARNINGS | Nov 04, 2026, 07:58 AM UTC Magle Chemoswed Reports Q3 Sales of SEK 70.9 Million M impact | EARNINGS | Nov 04, 2026, 07:56 AM UTC